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Background and Objectives. The arrbythmogenic stTect oi 
befs-adrenocer&v stimulation is ~omrde~ and mw di&r in txh- 
rmtc and normal myoardium. In this study we examined the 
di&rential e&t of ktaadrenerrir stimulation on ventriutar 
action potential duration and. h&e, dispersion of repolarizatlon 
in poteatsUy ischemic v?rsus nonlxhemic human ventrtcular 
myowJrdi”m. 
Melhe& S~uttaoeou~ biventricutar monopharfr artton paten- 
tials were recorded in 14 patients (28 recording site) during 
infusion of dobutamine in incremwt:.! do% (low dose 5 dkg per 
into, high dme 10 to 15 dkg per min) during atrlal pacing. 
Perfusion at the actbm poemtat recordtng sftc was assessed by 
iocorpwatiog myoenrdial prfuton sctnttgraphy with Injection of 
technetium-99m hoxakir-t.methoxy-2.mrthylpropyt.i~~~itril~ 
during the recording at peak doses of dobutmnine. Action raton- 
tii d&ion duringdob&amlne infusion was compared wiib that 
during alrial pacing to identical rates in the absacnte 01 dobu. 
tarnine. 
duralion. The mean I+ SEW value for the addtttonal e&t of 
dobutamine was 0.9 -C 2.5 ms with tow doses and -4 * 2.6 ms 
wdh high doses (p = NS). In seven wardings from potentially 
ivlhemic zones. low dose dobubmdne had a similar e&t fmean 
change -3.4 e.6.5 QIE; p = NS vs. normal zone values). Ho&w, 
the hi@ dose dobutamine invariably shortened the actian pa(en- 
tial duration by a mean of -22.9 t 2.9 ms. (p < 0.05 vs. low dos 
in iacbemir areas, p < 0.01 ~8. normd zone recordings). PaGag 
atone or the sdditior, of dobutamine had no sigaiticant effect oo 
the normal dip&on of action potential duration between two 
noniahemie recording sites. in recordinp in a normpl and an 
abnormally &used site, high dose dohutamtne signi!icanUy 
‘+tterti the dispersion of a&on poteottat duration. 
ResuuS. In 21 normal zone recordings, dobutamine produced a 
vtiabla r&et over that produced by atrtat priq to idm!iwl 
heart rate, eitbar ieotheniog or shortening the action potential 
The consistent ability of beta-adrenergic blocking agents to 
prevent sudden cardiac death and to reduce overall mortality 
in ischemic heart disease implies that beta-agonism is an 
important arrhythmogenic mechanism in the context of 
myocardial ischemia (I). However, studies cm the effect of 
beta-stimulation on arrhythmagenesis have been largely 
limited to isolated tissue and animal studies (2). The impor- 
tance of evaluating arrhythmopenic and antiarrhythmic 
mechanisms in the normal and ischemic human heart as 
Conclurions. These results suggst a diEwent &cl of Wa 
adrenergic sttmulalion in potenlialty hbemic compared w:P 
nonischemic human ventricular my&?ardium. The abtwnul di8. 
prsion of repolarll~tton thus created may wetl he important in 
hta~ror-modiatoda.rrhythmogonnisdurmyasrd,alIrh. 
rmia. 
d Am Co// Cardial 1992;20:896-903) 
well as in laboratory studies was recently emphasized (3)). 
One important arrhythmogenic mechanism is increased dia- 
Persian of repolarization (4-6). Therefore. in this study we 
examined the effect of beta-receptor stimulation on action 
potential duration and on dispersion of rep&&&m in the 
ischemic and nonischemic human myocardium to assess any 
differential response. We used dabutamine. a widelv used 
therapeutic anh diagnostic beta,-receptor agonist, and re. 
corded monophasic action potentials simultaneously from 
the right and left ventricular endorardium in patients with 
coronary artery disease. To disassociate rate-related eEects 
from direct membrane effects, recordings during steady state 
i ‘rial pacing at a rate just above that induced by dobu’amine 
were compared with those obtained during atrial pacing 
alone identical heart rates in the absence ofdobutamine. Our 
results show a significant difference in the electrophysiologic 
response to dobutamine infusion in ischemic areas compared 
with that in nanischemic areas. Such diaerences may be 
reeln’aiit :O bctn.recep::or+!wdiated arrhythmogenic mocha- 
nisms. 
Methods were rconented in the *hurt ax\ and horixmtal long md 
Summary. Recordings of the monophasic action potcn- 
vc”,cill iong axe, for d,splay and vwal aoalyslr. 
uals were obrainsd itmultaneously from vngle sites on the 
Procedure. Patena fasted for 4 10 o n. Routme Irf, 
ri& veotncular septum and left ventncu1ilr posterolnierol 
vcnwicular and coran::-) sngiography was performed by rhc 
fcmoial route wh use of the Jodkms rschnique and a 
wall during steady ttate atnal pacing at heart rate, expected 
to he achieved during dobutammc infuucron. Dohulamine wily 
nomomc awiogmphic dye IOmmpaque 350. Nycon;ed UK 
Ltd.). Lunb leads I and II and prccordial lead V, were uied 
infused in incremental doses. and steady state recordingr of 
for continuous ECG monitoring. 
action potentials were obtained at psccd ratesj,,r above that Catheter Ptlaeooxnt. A monophasx action potenlml re- 
induced by dobutamine. At peak dose of dobutamme. tech- 
netium-99m hexakis-2.melhoxy.2.methylpropyl-teonitnle 
cordmp carhctcr was introduced through shon femoral 
(Tc-r)m MIBI) was administered for rubseqwtt scmligw 
\healhb mto the right and left ventric!es. Stahlc recording 
phy and identification of ischemic areas. 
powions vere obtamed in the porterolatcral wall of the left 
Patients. Fourteen patients (six women and eight mew 
ventricle and the anterior aspect of the right ventricular side 
of the mterventricular septum. Gentle apposilion of the lip of 
aged 40 to 73 years [median 531) undergomg routine cardiac the endowdial surface resulted in monophasic action po- 
catheterization for investigation of chest pain were celcctcd rential signals wh an amplitude of 20 to 40 mV. A 6F 
at random for the stuJy. Ad but three patients had Ggnificant temoorary pacing electrode (Cordis UK) was placed m the 
coronary anen disease, single-vessel dtsease in eight pa- right alrial appendage or m the right atrial-superior vena 
tients and two-vessel disease ttt three Patients with unsvable cava junction for atrial pacing. 
angina. significant left main stem stenosis. attial fibrillation. Control monophasic a&n potential reewdings during 
significant conduction abnormaldies and inadequately con- pacing atone. Baseline recordings of the monophasic action 
trolled hypertension were not included in the study. No potential were obtained at paced heart rates starting at the 
patient was receiving antiarrhythmic drugs conventionally nearest multiple of 10 heats abovc the patient‘s rest hean 
considered to influence ventricular repolarizsdon. The ad- rate to a maximum of I20 heatsimin or to the highest rate 
ministration of beta-blockers was discontinued 48 h before possible without development of rianificant angina or atrio- 
the study. Patients also received IO mg of diazepam before ventricular block. Pacing rates were increased in steps of IO 
the study. Written informed ionsent was obtained from each beats. and each pacing rate was maintained for 2 min to 
patient, and the study protocol was approved by the ethical obtatn steady state action potential recordings at each heart 
committee of the hospital. rate. 
Eloetrophys!olcgla mtesarements. Monophasx action Dohutamiwinltion. Atrial pacing war discontinued and 
potentials were recorded with bipolar pressure contact mtuston uidom&xmne begu~n atarate aiS i;ghgpermk~ and 
silver-silver chloride custom-built catheter electrodes (Car- WPP increased in steps of 5 lrgikg per min at 5-min intervals 
dis UK 7D. The exploring electrode (I mm io diameter) was to a maximal dose of I5 &kg per min or to the development 
situated at the tip, and the reference electrode (1 mm in of angina. After 3 mitt ofeach incremental dobutamine dose. 
diameter) was situated 5 mm proximal to the lip and was atrial pacing was established for 2 mitt at a rate that was the 
Rush with the catheter wall. Signals were fed into a Gould nea.sst multiple of 10 beats above the rate induced by 
isolated preamplifier (model I I-5407-58) to provide patient dahutamtne: and monaphasic action potentials were re- 
isolation and then into a DC Gould universal amplifier corded 
(model 13-4615-58). The amplifiers were set to give an output Mvncsrdti pi-f&m rintigraphy. At Peak dobutamine 
of I V for 40.mV input with a frequency response of 300 Hz. dose. 350 to 400 MBq of TcH9m Ml81 was administered 
Signals were displayed on a Simonsen and Wee1 monitor intravenously. The patient was returned to the ward and 
(model MTS 102). A Gould Instruments chart recorder encouraged to eat a light fatty meal to facilitate hepatic 
(model 3400 3OV8 404-12) was used for hard copy record- clearance of the isotope. Myocardial perfusion imaging 
ings of the action potential signals and the routine ekctro- with SPECT was carried cod between I and 2 h after 
cardiogram (ECGl at a paper speed of 125 mm/s. The action injection ofthe tracer. Rest imaging was performed 24 h later 
potential signals were calibrated with a direct current milli- with the patient fasting for 4 hand after a second dose of 350 
volt source (Time Electronics mokl404 Sl. to 400 MBq of TcXJm MIBI. 
Myocardlal perfusion seintigraphy. Techneticm-99m Data analysis. Significant coronary artery disease was 
hexakis-2-methoxy-2.methylpmpyl-isonitrile (Tc-99m MIBI) defined as >50% stenosis in a major epicardial vessel. 
was used for myocardial perfusion scintigraphy with singk- Coronary angiographic data was interpreted by visual in- 
photon emission computed tomography (SPECT) in a :-day. spection, and the degree of stenosis was classified as mild 
two-dose protocol. Images were acquired with a single (representing <SOY? stenosis). moderate (50% to 70% rteno- 
detector rotating gamma cameralcomputer system (ICE 4M) sisl or severe (>7l% stenosisl. 
AC-Starcam) equipped with a low energy. high resolution The duration of the monophasic action potentials was 
collimator. Sixty-four 30-s images were acquired over a 360” measured by an observer who had no knowledge of the 
circtdar arc of rotation. Reconstructed tomographic slices angiographic and scintigraphtc data. Measurements were 
made at both 70% and 90% repolarization. Measurements at 
90% repolatization were made by drawing a tangent to the 
fastest phase of the repalarization curve (7). Both 70% and 
RW vaiues registered similar changes. Values at 70% repa 
lariation have been used for analysis. 
Dispersion of action potential duration between a left and 
right ventricular site in anv eiven patient was expressed bv 
s~btmcting the action potehl~al duration of the right ventricle 
fmm that of the left ventricle. These results are xvmssed in 
milliseconds with a positive (3-J or negative (-) &I indicat- 
ing, respectively, P !wger action potential duration in the left 
or the right ventricle. A change in dispersion of action 
ootential duration between two sites after an intervention 
&expressed as a change score. 
Mvocardial txrfusion SPECT imaees were intetweled bv 
one dbserver &o had no knowledgeof the angiogriphic anh 
action Potential data. In case of equivocal results, a consen- 
sus opinion was accepted. The SPECT images were read as 
normal if they were without defect in the initial set or 
abnormal if there were reversible or fixed defects. The 
localization of defects was related to coronary artery distri- 
bution according to the standard anatomic relation in which 
anterior and septal abnormalities are considered to be in the 
territoy of the left anterior descending artery, lateral or 
posterior defects in the territory of the left circumflex artery 
md inferior ahnomnlities in the territory of the right core- 
nary artery. Apical defects could relate to the territory of 
any major coronary anery (6). 
The position of the monophasic action potential catheter 
in the ventricle was documented at the time of cardiac 
catheterizalion by biplane cinematography and subsequently 
related to the petfusion abnormalities an the perfusion scan. 
Recordings from sites in the left ventricle cn right ventricular 
side of the interventricular septum that corresponded to 
areas on the scintigram showing reversible perfusion defects 
were considered ischemic wne recordings and those from 
areas with normal perfusion pattern as normal zone record- 
ings. 
The doses of dobutamine used (in increments of 5 lrglkg 
per mitt) ranged from 5 to IS @/kg per min. For purposes of 
differerdkding low dose effects from hiih dose effects. a low 
dose was defined as 5 &kg per min and a dose of IO &kg 
per min as a high dose. 
Values are reported as mean * SEM. Statistical analysis 
of comparisons between groups was made by using analysis 
of variance and paired comparison of means IANOVA). A 
p value < 0.05 was considered statistically significant. 
Results 
Simultaneous recordings of monophasic action potentials 
from the right and left ventricles were obtained in I4 patients 
Fire I. Change in steady state monophaic action Qotentlal durd- 
Lion during dohutamine infusion. Eeeh point rcpresamr the addi- 
tional erect ofdobutamine over thnt of pacing. In the normal zone 
(Table I). As assessed by perfusion xintigraphic character- 
recordings. dobutamme lengthens the acnon potential durauon 
WD, in some and shorten it in athcn A sm,dar pattern we\ 
istics at the recording sites. 21 recordings were from nonisch- 
obr-red for the low dose dobutamme mlwions m the ~whem~c 
zones before the onset olischemia. The higher dosesoldobutamme 
emit areas and 7 from ischemic areas. Action potential 
in rho ischemic zones invarihhty shortened the ~cnon potential 
duration in all the recordings t’p < 0.05 compared with Iow dose 
dobutamine in Ihe ischemic zone: ‘*p < WI compared with high 
dose dabulamine in the normal zonel. 
had 3 tieht ~tenosx m the oroxima! iett cwxmflex anerv. 
The :I& vem~~ular r&ding site lsmgle arrow on the 
SPFCT uowe in oanel A) was ma nonischemic xme and the 
loft rcntricular site idouhle arrow on the SPECT image) was 
in a zone that showed reversible perfusion defects in re- 
iponw to dobutaminc. Increasing pacing rate in the absence 
of dohutamine from 70 to IO beat&in produced the 
expected thortening in bath right ventricular lpnel B) and 
left ventncular (panel C) recordings. At the right ventricular 
site. dobutamine infusion did not significantly influence the 
actmn po:ential duration for either the low dose 15 &kg per 
min: paced rate 70 bcatslmin) or the high dose (I5 w/k::,er . _. 
mm: wed rate 100 beats:minl. In the left ventricular site. 
low do\e dobutamine infusion before the onset of ischemia 
resulted m a small increase in action Qaential duration. At 
higher dews in the presence of whemm. a wbstantial 
shortening ofaction potential dwatton over that produced by 
pacing BI an identical rate is seen. 
adjacent areas ofmyocardium. However, because the paints 
tn Ftgure 1 include observations in different patients, we also 
analyzed the results (Fig. 3) obtained at two sites in the same 
patients. Simultaneous recordings in two normal areas were 
obtained m seven patients and simultaneous recordings in 
DisQwsion of Wkm putential duration. The contrast be- 
tween the effect of high dose dobutamine on normal and 
ischemic rows is evident in Figure I. suggesting a possible 
effect on the disoersian of action axe&l duration io 
recordings obtained during dobutamine infusion .aere 
matched with control recordings obtained at identical atria! 
paced rates before dobutamine infusion. With incremental 
pacing action potential duration shortened as expected as 
heat? rate increased; with dobutamine. there was an addi- 
tional effect on action potential duration (Fig. II. 
Nonkiclnmic mnx res~onsea. As shown in the recordings 
from nonischemic areas in Figure I. low doses of dobu- 
tamine either lengthened or shortened action potential dura- 
tion from the value achieved with pacing (lengthening in 9. 
shortening in 7 and no change in 5). The mean change in the 
action potential duration was 0.9 * 2.5 ros. Similarly. with 
high dose dobutamine infusion, 6 recordings howed lergth- 
ening. I2 showed shortening and 3 showed no change in 
action potential duration. The mean change was -4 + 2.6 ms 
(p = N’S compared with results of low d&e dobutamine). 
Lsckmk zone responses. In recordings during the low 
dose dobutamine infusion. lengthening of adion potential 
duration was observed at three sites and shortening at four 
,;:a: the mean change was -3.4 + 6.5 ms (p = NS 
compared with nomtal zone values). High dose dobutamine 
resulted in shortening of the action potential duration in all 
both a normal area and an ischemic area were obtained in 
another seven patients. Dispersion of action potential dura- 
tion between & two recording sites was compared in 
recordings obtained in the following situations: I) during 
?acing alone at a rate corresponding to that for the lowest 
dose of dobutamine. 2) during pacing alone at a rate corre- 
sponding to that for the highest dose of dohutamine, and 3) 
during pacing in combination with the highest dose of 
dobutamine infusion. In Figure 3A. the positive dispersion 
values above the zero line indicate a longer action potential 
duration in the left ventricle and the negative values below 
the zero line indicate a longer duration in the right ventricle. 
The graphs show the direction of change in the action 
potential duration between the two ventricles. Alterations in 
the dispersion of action potential duration among the three 
situations are expressed&a change score (Fig. 38). Change 
in pacing rates alone or the addition of dobutamine produced 
no significant alteration in dispersion of action potential 
duration between two tmnischemic recording sites. In re. 
cordings at one normal and one ischemic site. however, the 
higher doses of dobutamine significantly altered the dieper- 
sion change scores (p < 0.01 compared with the change 
seven recordings in the ischemic zone. The changes ob- scores in the normal zones and the change score comparing 
served (mean -22.9 r 2.9 ms) were significantly different low and high pacing rates in the ischemic zones). 
frmo those recorded during low dose dobutamine infusion in Patient twqome to pacing and dobtttmnirta During the 
the ischemic region (p < O.OS) end duriug high dew infusion pscing-ai~ne sec:ion of the protos~l, no :a!ient developed 
in the normrd zone (p C 0.01). angina or ST segmenl changes on the monitored surface 
Figure 2 shows perfusion scintigrams and monophasic ECG leads. During dobutamine infusion, IO patients had 
action potential signals recorded in Patient I. The patient chest pain that was associated with ST segment changes in 
Figure 2. Monophasie radon pteaialr re- 
corded simultaneuusly from the right yen. 
tricular septum lpnnet B, and the left “a- 
trieutar posterotaterat wall tpP”rl C, 
together wbh Tc-99m MIBI tomographic 
myocardial perfusion images (p-anel A) em- 
bracing the IWO reeor.3ing zones ,sec te*, 
for dew&). In pa4 A. the rb@ arrow 
depkls the zune of recording fmm the righl 
ventricular side of the interwmictdar sep 
rowi~dicatestheareaofrecordingImmthe 
t&t venlricutar postemtateral wall; whh 
dobutamine infusion. this area dcvetops a
perfusion abnormality that reverses on the 
rest scan. Action potential duration. mea- 
sured al 70% repckizadon in milliseconds. 
is shown within the signals in pa&B and 
C. HLA = horizontal lung axis; ppm = 
pulses perminute;SA = shortaxis;VLA = 
wtica! tong axis. 
5 paGents (ST depression in 4 and elevation in I). In three 
patients, troublesome palpitation occurred that required 
cessation of dobutamine infusion (Table I). 
Discussion 
Main findings of present sludy. Although the effects of 
beta-stimulation of the action potential duration have been 
documented in isolated tissue and animal studies (9-12). the 
differential effect (dispersion) belween ischemic and normal 
human ventricular myocardium has not been previously 
studied. Accordingly, we studied the etkct ofdobutamine, a 
widely used beta,-receptor agonist, on human ventricular 
action potential duration, comparing recordings from nomx4 
and tmtentially ischemic areas of myocardium. The presence 
or absence of myocardial ischemia at he recording site was 
identified by perfusion scintigraphy using Tc-99m MlBl 
injected at the time of the action potential recording prow 
dure. With higher doses of dobutamine, recordings from the 
ischcmic area registered consistenr shortening of rhe action 
potential duration beyond that induced by pacing to an 
identicnl heart rate in the absence of dobutamine. In cou- 
Figure 3. A, Dirpersion ofaction patemal 
duration (APD) between the right and left 
ventricles. In sewn Pauentr. both right 
and left ventricular recording sites wex 
normally perfused (left patwlj and in an- 
other seven patients. one recording ate 
bad normal wfusion whereas !he other 
had an abnormal perfusion pauem (right 
pane!). Points above the dsshed line at 0 
Ipositive) indicate a longer action potential 
duration in the left ventrisk and rbose 
below the line Inegative) indicate a longer 
action potential duration in the right yen- 
triclc. The directions of change m action 
pztentiat duration in three situaions are 
shown: dkng pacing atom at a rate COT- 
responding to that for the lowest dose of 
dobutamine (AI. during pacing atone al a 
rate corresponding to that for the highest 
dose of dobutamine (Et), and during pacing 
togelher with the hghest dose of dobu- 
tarnine (CL B, Mean change SEO~~S com- 
paring the three situations. Change in pat- 
ingrates or the addition of dobutamine did 
not significantly alter the action patenliat 
duration dispersion between the two nor- 
mally perfused areas Cleft panel). le re- 
ccrdings betweenonenom~al andone iscb 
emit site (tight f.aml), the higher dose of 
dohutamire prcduced a significantly dif- 
Went dispersion change score (‘p < 0.01 







trast, in recordings from normal myoeardium. a variable 
resuonse to dobutamine. either lengthening or shortening of 
a&on potential duration, was observed. 
Reirtiou iu previous studies anti mecbattismv. The vari- 
Jle response of action potential duration in the normal zone 
(and during low dose dobutamine infusion in the ischemic 
done befok the onset of ischemia) is consistent with the 
diversity of response to beta-stimulation in reported studies. 
Studies that examined the influence of beta-receptor stimu- 
lation on ventricular action potential duration have demon- 
strated lengtberdttg (13.14). shortening 110.15) or a biphasic 
elTect (I I). These differences have been attributed to varying 
drug concentrations, relative dpha- and beta-components 
and ditTennccs in receptor density (16). Opthof et al. (17) 
recently demonstrated in dog hearts wide individual varia- 
lions in the response of refmctoriness (and. by inference, 
action potential duration) to sympathetic stimulation. The 
reason for this variable response is not clear. Although 
dobutamine is predominantly a b&,-receptor agonist. it also 
has alpha-receptor effects. Alpha-receptor stimulation pro. 
longs action potential duration by its action on calcium 
currents at the plaleau level, vh- beta,-stimulation 
shonens action potential duration by accelerating the time- 
dependent currents. The variable responses observed might 
therefore be explained by the existence of myowdial areas 
with alpha-receptors only. An additional consideration 
would be mechanaelecttical feedback whereby the force of 
contraction and degree of stretch alter repokuization (18). 
The pronwnced and consistent shortening of action 
potential duration in the ischemic myocardium in response 
to the higher doses ofdobutamine is probably mainly due to 
the induction of ischemia and the enhancement of iction 
potential duration shortening that ociws as a direct effect of 
icchemia. (IY-21) Such ischemia would be expected because 
dobutumine is known to increase myocardial oxygen de- 
mand. Furthemwre, the presence of inchemia at the time of 
the recordingsandat he site wasdocu~mented by the Tc-YYm 
MIBI perfusion scintigraphy. However, alternative or addi- 
tional mechanisms may well be inportard in the uniform 
shortening of action potential duration during high dare 
dobutamine b&ion in the ischemic zone. These may in- 
clude a direct effect of baa-agonists on membrane currents 
and interactive effects of bela-stimulation on rate-adaptive 
mechanisms nf ac:ion potential duration (22,23). 
Dispwsion of action wtential duration. The invariable 
shortening of nction potential duration in an ischemic area 
compared with the variable effect in the normal area would. 
by inference, alter the dispersion ofaction pOfcntial duration 
in the ischemic and nonischemic sites. This is evident from 
Figure 3. in which paired sites of normal myocardium and of 
nnrmal and ischemic myocardium are compared. Dispersion 
ofrcpolarization and consequent inhonogeneity of recovery 
ofexcitability arc important in reentrant arrhythmias. In the 
normal rnyocurdium. the time course of refractoriness is 
mughly parallel to the time course of repolarization (241. In 
the ischemic myocardium, however, refractoriness outlasts 
rcpolarization (postrepolcrization refractoriness) (16). It is 
not possible therefore tn equate precisely our observations 
on action potential duration with dispersion of refractoriness 
between the tschemic and nonischemic regions. although in 
the initinl phases of ischemia. changes in the two variables 
may occur at the same time (25). It is also not possible to 
define the exact degree of dispersion required to initiate 
reentrant arrhythmia because of the wide disparity in sub- 
strates, nature and size of reentrant circuits. Experimental 
results (6.26,27) have indicated valueS ranging fmm appmx- 
imatcly 80 ms to IO ms. An alteration of a few milliseconds 
may be all that is necessary to initiate reentrant tachyar- 
rhythm& given the appropriate wavelength. The degree of 
atteration in dispersion observed in this study could there- 
fore have been af sufficient magnitude to influence reentrant 
mechanisms. 
Implications. Bcta.blockers have been found tu be the 
only antiarrhythmic druas that effectively reduce sudden 
cardiac death-in coron”& artery disease (28-31). However, 
the mechanism by which they exert their antiarrhythmic 
effect in &hernia has been variously described and is 
unclear. Catccholamines have been shown (16,3X33) to 
prmnute or induce arrhythmias in nurmal cardiac tissue by 
enhanced automaticity, triggered activity or reentrant mech- 
anisms. The diffcrcnlial effects of beta-stimulation on the 
action potential duration in the normal and ischemic human 
heart demonstrated in the present study suggest a salutary 
role of beta-blockade by reducing the dispersion of rcpolar- 
iaation in z&cent areas of the mvocardium. 
Liiitatiu& of the present study. An important limitation 
ofthe studv mtocol is the inabilitv to exclude the oossibilitv 
of a degree of ischemia due to thebacing itself. H&ever, ih 
contrast to pacing with dobutaminc, during pacing alone no 
patient experienced angina or showed ST segment changes 
on the monitored ECG leads. Hence, any ischemia induced 
by the pacing itself is likely to have been minor. Another 
possible limitation is that our re~uhs may have been influ- 
enced by background sympathetic activity of the individual 
patients. Some of our patients had been receiving long.ternt 
therapy with beta-blockers, including atenolol. Although 
such treatment was discontinued 48 h b&ore the study, there 
may have been residual eflects at the time of the study. In 
addition, beta-blockers may affect receptor levels for ~uae 
time after thrir USC i( discontinued. Individual variability 
may have resulted from differences in beta-receptor wtsi- 
tivity after the drugs were withdrawn. However, there w”% 
no significant ditTerence in the rest hean rate between 
patients who had or had not been receiving beta-blockers. It 
is therefore unlikely that variations in background nympa- 
tbetic activity would have influenced the overall effect. 
Finally. tolerance to the maximal dobutamine dose differed 
among patients as u result of differences in the severity of 
their coronarv artery disease. Therefore. observation” had 
to be made over a range of heart rates determined by 
individual lcvcts of tolerance. Although the effect of inter- 
ventions on action potential duration may be influenced by 
basic cycle length, such influence would be minor over the 
relatively narrw range of cycle lengths used in the present 
study. 
Conclusions. This study examined the direct effects of 
dobutamine. a commonly used beta,.receptor agonist, on 
action potential duration. In normal arex of myocardium, a 
variable effect was demonstrated, a finding consistent with 
experimental data. In areas susceptible to ischemia. irch- 
emia-inducing doses of dohutamine consistently shortened 
the action potential duration. Such rcghmal effects of beta- 
adrenergic stimulation cun theoretically alter dispersion of 
action potential in adjacent areas of nomtal and ischemic 
myocardium. By reducing such dispersion beta-blockers 
would bc expected tn minimize the pmpensity for reentrant 
arrhythmias in ischemic myocardium. 
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